A number of medical and cosmetic applications involve controlled injection of substances into the body.
A medical syringe is a simple piston pump consisting of a plunger that fits tightly in a cylindrical barrel. The plunger can be pulled and pushed along inside the barrel, allowing the syringe to take in and expel a fluid through an orifice at the distal open end of the barrel. The distal end of the syringe is typically fitted with a hypodermic needle to introduce the barrel's fluid into a patient. Surprisingly, other than the materials used to make a syringe, conventional disposable syringes are much the same as the very earliest syringe designs.
Classic syringe/needle systems are far from optimal for the administration of today's injectable aesthetic compositions. Hydrogel-based dermal fillers can be quite difficult to inject using the conventional syringe/needle system or conventional injection techniques. Many dermal fillers are by their nature highly viscous, thus requiring relatively high extrusion forces, especially when injected through preferred fine gauge needles. Moreover, these materials can be injected into the face to correct wrinkles, including fine wrinkles as well as other minor defects in skin, and therefore, must be sometimes injected in trace amounts, and always with very high precision. Interestingly, these dermal fillers are commonly introduced into skin using standard needle and syringe combinations.
Using a traditional syringe, physicians can be required to supply possibly significant force, which may reduce the practitioner's ability to control the syringe. Further, traditional syringes typically require the user's hand to be placed a significant distance from the site of the injection in order to operate the plunger, which may also lead to inaccuracy. Automated injection machines, which supply the force required to perform the injection using a motor, may reduce some of these problems. However, some motorized injection devices have the disadvantage that they may be heavy and bulky. This added bulk and weight may lead to a lack of control because of user fatigue, balancing issues, etc.
As an additional complexity, it can be desired to mix fluids prior to or during an injection based on any number of factors such as, for example, the size of a patient's wrinkle. To increase user control of injections and accuracy of mixing injectable fluids, it is desirable to provide users with new types of injection devices. Accordingly, a need exists for further development of injection devices.
In one embodiment, injection devices can include: (a) at least one processor; (b) at least one input device operatively coupled to the processor; (c) a first cartridge that defines a first chamber which is configured to contain a first injectable fluid (e.g., a dermal filler); (d) a second cartridge that defines a second chamber which is configured to contain a second injectable fluid (e.g., a phosphate buffered saline); (e) a drive unit operatively coupled to the processor; (f) a mixing unit configured to mix the first injectable fluid and the second injectable fluid; and (g) at least one memory device storing instructions. In operation, when the instructions are executed by the at least one processor, the injection device selects a dilution ratio of the first injectable liquid and the second injectable liquid. In one embodiment, the injection device selects the injection ratio based on a user's input. Using the selected dilution ratio, the injection device produces an injectable mixed fluid by diluting the first injectable liquid with the second injectable liquid. Thereafter, the injection device extrudes the injectable mixed fluid.
In one embodiment, a modular injection system includes a handheld injector device and a control device which is separate from the handheld injector device. In one embodiment, the handheld injector device communicates with the control device using a communication wire. In one embodiment, the handheld injector device wirelessly communicates with the control device. In one embodiment, the handheld injector device includes a drive unit and a mixing unit which is configured to mix injectable fluids. In one embodiment, the control device includes the drive unit. The control device can include: (a) a first cartridge defining a first chamber configured to contain the first injectable fluid; and (b) a second cartridge defining a second chamber configured to contain the second injectable fluid. In one embodiment, the modular injection system enables a user to select a dilution ratio of the first injectable liquid and the second injectable liquid. Based on the selected dilution ratio, in one embodiment, the modular injection system can produce an injectable mixed fluid by diluting the first injectable liquid with the second injectable liquid.
In one embodiment, the control device is configured to be secured to a wrist of a user of the modular injection system.
In one embodiment, the drive unit includes gear motors and racks operatively coupled to the gear motors. In this example, the racks are operatively engaged with plungers. In another example, the drive unit includes a pressure source and a pressure regulator.
In one embodiment, the modular injection device selects an injection rate for the mixed injectable fluid. In this example, the modular injection device extrudes the injectable mixed fluid based on the selected injection rate. In another example, the modular injection device selects a first injection rate for the first injectable fluid, and selects a second injection rate for the second injectable fluid.
In some examples, the modular injection device may be configured to display any of the injection rates. In some examples, the modular injection device displays information indicating a volume of fluid injected.
Additional features and advantages are described herein, and will be apparent from, the following Detailed Description and Figures.
Described herein, generally are modular injection systems including a handheld injection device and a control device. In some embodiments, the control device is separate from the handheld injector device. In other embodiments, the control device is substantially separate from the handheld injection device or partially integrated with the handheld injection device.
In one embodiment, the handheld injection device includes a grippable housing and a mixing unit configured to mix injectable fluids to produce an injectable mixed fluid. In one embodiment, the control device includes: (a) cartridges configured to contain the injectable fluids; and (b) an injection drive mechanism or a drive unit configured to cause: (i) the mixing unit to mix the injectable fluids to mix; and (ii) the handheld injection device to extrude the injectable mixed fluid.
In the general operation of one embodiment, before an injection occurs, the control device can enable a user to select a dilution ratio of a first injectable fluid (e.g., hyaluronic acid (“HA”)) and a second injectable fluid (e.g., phosphate buffered saline (“PBS”)). As the injectable fluids move from their respective chambers in the control device to the needle in the handheld injection device for extrusion, using the mixing unit, the handheld injection device can dilute the first injectable liquid with the second injectable liquid based on the selected dilution ratio. In one embodiment, the control device also enables the user to control the rate at which the mixed fluid extrudes from the handheld injection device.
As mentioned above, a number of medical and cosmetic procedures involve the controlled injection of liquids, gels, and other fluids. For instance, procedures involving the injection of botulinum toxin or the injection of dermal fillers, may require highly controlled injections. Using the modular injection systems and methods disclosed herein, users need not supply some or all the force required to extrude the mixed injectable fluid. The modular injection systems and methods described herein can provide highly controlled injections by having the modular injection system: (i) supply the force which extrudes the injectable fluid through the needle; and (ii) extrude the fluid at a user controlled rate and with a user controlled dilution ratio, leaving the user free to concentrate on the injection itself, e.g., positioning of the needle.
Advantageously, the handheld injector device of the present disclosure can be lightweight and easy to manipulate and grip. Many of the heavier components of the modular injection system can be housed in the control device that is separate from the handheld injection device. In one embodiment, the control device is mountable to a user's arm or wrist to allow the user to view the display device while operating the handheld injector device within the same field of vision.
Referring now to
In this embodiment, as illustrated in
In this embodiment, first portion 104 includes: (a) housing or body 108; and (b) input device or inject button 110. Using communication cable 112, inject button 110 is operatively connected to a processor located in control device 102 (discussed in more detail below). The inject button may start and stop the injection process.
As illustrated in
Housing 108 may have a grippable housing, which may be made of any suitable material, e.g., metals, thermoplastics, thermoplastic elastomers (TPEs), silicones, glass, etc., or any combination of materials. Housing 108 may be shaped to comfortably accommodate a user's hand. A portion of housing 108 designed to be gripped may be textured to provide a secure grip, or may be covered in a layer of material designed to provide a secure grip.
In different embodiments, handheld injection device 100 may be ergonomically designed to facilitate injection for a wide variety of hand shapes, sizes and gripping positions. Advantageously, the handheld injector device can be easy to manipulate and grip.
In this embodiment, mixing unit 114 is configured to mix injectable fluids by directing the injectable fluids into half circle pathways. For embodiment, as illustrated in
In one embodiment, the mixing unit is configured to mix injectable fluids by directing the injectable fluids into a spiral mixing path. For example, as illustrated in
In one embodiment, the mixing unit is configured to mix the fluids by forcing the injectable fluids into a helical path. For example, as illustrated in
In one embodiment, the mixing unit includes corrugated sections which are configured to mix the injectable fluids. For example, as illustrated in
Each of the mixing units described above are static. It should be appreciated that in other embodiments, the mixing unit may be dynamic. It should also be appreciated that in different embodiments, the injection device may include any suitable mixing unit, including any of the mixing units described herein.
As shown in
In one embodiment, handheld injection device 100 includes a power system. In this embodiment, handheld injection device 100 is connected to the control device using a cable or wire which supplies power to the power system from the control device. In one embodiment, where the handheld injector device houses certain components (e.g., a processor), the cable or wire is connected to these components. In one embodiment, handheld injector device 100 includes a motor, a processor and a power supply system configured to supply power to the motor and the processor. In this embodiment, power wires from the control device may be attached to the power system. In one embodiment, the cables or wires which connect the handheld injection device and the control device are removable.
In one embodiment, the handheld injector device wirelessly communicates with the control device. In one embodiment, the handheld injector device includes a transmitter and receiver, and the control device includes a transmitter and a receiver. In operation, using a wireless device, a communication channel may be established between the handheld injector device and the control device. Once established, the wireless communication channel may be used to exchange information and control signals between the handheld injector device and the control device as it would be exchanged using an embodiment with the cable. Because wireless communications have a greater chance of being disrupted than communications over a cable, the handheld injector device may be configured to react if wireless communication should be lost. For example, the handheld injector device may poll the control device periodically to sense whether it is in wireless communication with the control device. Should a poll fail, the handheld injector device may be configured to stop operation, continue operation using locally stored configuration parameters, and/or activate an alarm.
In one embodiment, the modular injection system includes both wireless and cable communication. For example, the handheld injector device and control device may each include wireless devices and a cable connection. In one embodiment, the wireless devices may not be used when the handheld injector device and the control device are connected via cable. In one embodiment, the handheld injector device houses an optional power source. For example, the handheld injector device may be configured to draw power over a cable, when attached the control device via cable. In this case, the optional power source need not be installed in the handheld injector device, reducing the weight of the handheld injector device. However, should the wireless devices be used for communication instead of the cable, the optional power source may be installed in the handheld injector device, which may be configured to draw power directly from the power source when in that configuration.
As illustrated in
In this embodiment, control device 102 is portable. In one embodiment, control device 102 may be strapped to the user's wrist via a VELCRO® strap or other typical strap or connector. For example, as illustrated in
In this embodiment, first cartridge 132 is separate from second cartridge 136. In an alternative embodiment, cartridges may be combined into a single component. For example, as illustrated in the
In one alternative embodiment, control device 102 includes a single cartridge which defines a plurality of chambers which contain the fluids. Referring to
In one embodiment, where modular injector system 10 includes a single cartridge, the single cartridge is operatively connected to a flow/pressure regulator. For example, as illustrated in
In one embodiment, the modular injection system attaches to and operates a standard needle and cartridge combination. That is, in this embodiment, the modular injection system does not include any cartridges. Rather, the modular injection system is configured to receive the cartridges. In one embodiment, the modular injection system is attached to the cartridges using a luer slip or luer lock attachment. In one embodiment, the cartridges include a protruding or snap feature used to lock the cartridges into the modular injection system when it is fully inserted. In another embodiment, the inner body of the handheld injection device includes the protruding or snap feature. In other embodiments, the control device includes the protruding or snap feature. In one embodiment, the cartridge includes a ring which seals the cartridge into a cartridge slot of the modular injection system.
The modular injection system may also include a cartridge retention and ejection mechanism. This mechanism may facilitate loading of, e.g., pre-filled, disposable cartridges. The mechanism may also provide for the rotation of cartridges. In one embodiment, the handheld injection device includes the cartridge retention and ejection mechanism. In another embodiment, the control device includes the cartridge retention and ejection mechanism.
In one embodiment, the modular injection system houses chambers itself to contain fluids to be injected. The chambers can be housed in the handheld injection device. In this embodiment, a needle is attached directly to the handheld injection device. The chambers can also be housed in the control device. In one embodiment, the modular injection system includes a cartridge housing in which the cartridge(s) may be secured. In another embodiment, the cartridge housing is substantially in the form of a tube. The cartridge housing may be designed to hold a disposable, pre-filled cartridge. The cartridge housing may be all or partially transparent, allowing a user to view the cartridge during operation. For example, the cartridge housing may provide a user with a view of both a cartridge in the housing and also a cartridge plunger which may extrude fluid from the cartridge when the modular injection system is in operation.
In one embodiment, the cartridge(s) is made of cyclic olefin copolymer (COC). Any other suitable materials may be utilized.
In one embodiment, each cartridge is filled using different dedicated filling tips. Once filled, a sealing tip may be employed to prevent mixing of the injectable fluids while in storage.
In one embodiment, the cartridge includes a needle or is configured to be coupled to a needle. In one embodiment, using a luer tip, the at least one cartridge is coupled to a needle. The needle itself may have any suitable gauge, for example, a gauge between about 10 and about 33. In one embodiment, the needle is a 30 G×¾″ needle.
In one embodiment, after a desired amount of fluid has been injected into the patient, the user of the injection device may remove and discard the used cartridge(s) along with the needle.
It should be appreciated that, in different embodiments, modular injection system 10 is configured to include or attach to any suitable cartridge.
In one embodiment, the injectable fluids (e.g., the first injectable fluid and/or the second injectable fluid) include at least one biocompatible material. These biocompatible materials include, but are not limited to, dermal fillers, hyaluronic acid-based dermal fillers (e.g., Juvederm™ Ultra and Juvederm™ Ultra Plus (Allergan, Irvine, Calif.)), hydrogels (i.e., superabsorbent natural or synthetic polymers), organogels, xerogels, encapsulated and/or cross-linked biomaterials, silicones, glycosaminoglycans (e.g., chondroitin sulfate, dermatin sulfate, dermatin, dermatin sulfate, heparin sulfate, hyaluronic acid, o-sulfated hyaluronic acid), polysaccharides (e.g., chitosan, starch, glycogen, cellulose), collagen, elastin, local anesthetics (e.g., Benzocaine, Chloroprocaine, Cyclomethycaine, Dimethocaine/Larocaine, Propoxycaine, Procaine/Novocaine, Proparacaine, Tetracaine/Amethocaine, Amino amides, Articaine, Bupivacaine, Carticaine, Cinchocaine/Dibucaine, Etidocaine, Levobupivacaine, Lidocaine/Lignocaine, Mepivacaine, Piperocaine, Prilocaine, Ropivacaine, Trimecaine), drugs, bioactive agents, antioxidants, enzyme inhibitors (e.g., anti-hyaluronidase), vitamins, minerals, water, saline, light curable or light activated materials, vaccines, and pH curable or pH activated materials. Other biocompatible materials not mentioned above are also considered within the scope of the present description.
In one embodiment, the second injectable fluid includes a bioactive agent which facilities delivery of the first injectable fluid injection (e.g., to reduce extrusion force and/or viscosity). Additional bioactive agents may include anti-proliferatives including, but not limited to, macrolide antibiotics including FKBP-12 binding compounds, estrogens, chaperone inhibitors, protease inhibitors, protein-tyrosine kinase inhibitors, leptomycin B, peroxisome proliferator-activated receptor gamma ligands (PPARγ), hypothemycin, nitric oxide, bisphosphonates, epidermal growth factor inhibitors, antibodies, proteasome inhibitors, antibiotics, anti-inflammatories, anti-sense nucleotides and transforming nucleic acids. Drugs can also refer to bioactive agents including anti-proliferative compounds, cytostatic compounds, toxic compounds, anti-inflammatory compounds, anti-fungal agents, steroids, chemotherapeutic agents, analgesics, antibiotics, protease inhibitors, statins, nucleic acids, polypeptides, growth factors and delivery vectors including recombinant micro-organisms, liposomes, and the like. Combinations of additional bioactive agents are also within the scope of the present description.
Other injectable fluids (e.g., the first injectable fluid and/or the second injectable fluid) may include toxins such as botulinum toxins. The botulinum toxin can be selected from the group consisting of botulinum toxin types A, B, C1, D, E, F and G, a pure or purified (i.e., about 150 kD) botulinum toxin, as well as a native or recombinant botulinum toxin. The material can comprise between about 1 unit to about 20,000 units of the botulinum toxin or a therapeutically effective amount, and the composition can comprise an amount of botulinum toxin sufficient to achieve a therapeutic effect lasting between 1 month and 5 years. The botulinum toxin can be reconstituted within the device as described elsewhere herein or before the cartridge is placed in the device. The botulinum toxin can be reconstituted with sterile 0.9% sodium chloride (saline).
In one embodiment, the dilution ratio is 1 to 100 units of botulinum toxin per 0.1 mL of saline. More preferably, in one embodiment, the dilution ratio is 1 to 50 units per 0.1 mL of saline, or 1 to 10 units per 0.1 mL of saline. In one embodiment, 4 units per 0.1 mL of saline are used. The dilution ratio can be highly dependent on the type of botulinum toxin used or combination of botulinum toxins used.
As illustrated in
As illustrated in
In operation, in this embodiment, drive unit 140 drives linear motion of the plungers causing mixed injectable fluid to be extruded. More specifically, first gear motor 144 causes first gear 146 to turn, thereby driving the linear motion of first rack 148. First rack 148 engages first plunger 150, thereby causing the first injectable fluid to flow from the first chamber, through first tube 132, to mixing unit 114 of handheld injection device 100. The second gear motor causes the second gear to turn, thereby driving the linear motion of second rack 152. Second rack 152 engages the second plunger, thereby causing the second injectable fluid to flow from the second chamber, through second tube 136, to mixing unit 114 of handheld injection device 100.
In one embodiment, the rotational output of the motors drives the linear motion of the racks through worm gears. In another embodiment, the rotational output of the motors drive the linear motion of the racks through concentric gearing of an internally threaded gear to a threaded rack.
It should be appreciated that any of the motors discussed herein may be any suitable electric motor capable of supplying the necessary force. In one embodiment, the motors are operatively connected to the plungers via certain of the drive units discussed herein. In some embodiments, the drive units function to transfer the rotational motion of the motors into the linear motion of the plunger.
In one embodiment, modular injection systems can include a control system. The control system can include at least one processor, at least one memory device operatively connected to the at least one processor, at least one input device operatively connected to the at least one processor, and at least one output device operatively connected to the at least one processor. For example, as illustrated in
The at least one processor may be any suitable processor unit of a kind normally used in such devices. In one embodiment, the control system can include one or more digital processors, such as a digital microprocessor or a micro-controller based platform. In one embodiment, the control system includes one or more analog control units such as a suitable integrated circuit or one or more application-specific integrated circuits (ASICs). In one embodiment, the control system is in communication with, or operable to access or exchange signals with the at least one memory device. In this embodiment, the memory device stores program code or instructions, executable by the processor(s), to control the injection device. In one embodiment, such memory device can include: (a) RAM (MRAM); (b) ferroelectric RAM (FeRAM); (c) read only memory (ROM); (d) flash memory; (e) EEPROM (electrically erasable programmable read only memory); or a suitable combination of such memory devices. It should be appreciated that any other suitable magnetic, optical, or semiconductor memory may operate in conjunction with, or as part of, the injection device.
In one embodiment, the output devices include at least one display device. In one embodiment, the display device includes an LCD screen which is located on a front of the injection device, and allows a user to interact with the system. In one embodiment, the LCD screen displays a dot matrix pattern. In one embodiment, the display device includes LED technology. In one embodiment, the modular injection system causes an LED display device to display proprietary artwork. In one embodiment, the display device includes electroluminescent panels. In one embodiment, the display device includes an interface. Using the interface, the user may control the operation of the device.
The modular injection system may be configured to cause the display device to display at least one of, for each fluid contained: (i) the volume that has been injected; (ii) the volume remaining; (iii) the starting volume; and (iv) the speed or injection rate. The display device may also display at least one of: (a) the total volume of fluid that has been extruded or injected; (b) the speed or rate of injection of the mixed fluid; (c) the dilution ratio of the fluid being injected. In addition, other information may be displayed to facilitate different functions. For instance, the display device may also display configuration screens, summary information, error indicators in the case of a malfunction, and/or battery power information.
In one embodiment, the input devices include inject button 110. The inject button may be located on handheld injection device 100 in a position which is conveniently accessible by a user's fingers or thumb during injection. The inject button may start and stop the injection process. In one embodiment, the user may press and hold the inject button to begin the injection, and may release the inject button to stop the injection. In other embodiments, the injection process may work in other ways. For instance, the user may press the inject button once to begin the injection and a second time to stop the injection. In other embodiments, the injection process starts based on a user pressing switch or some other actuator.
In one embodiment, control system 154 includes at least one input device (e.g., a keypad, a button, a dial or a switch) which enables a user to control the overall speed or rate or volume of the extrusion. In one embodiment, control system 154 includes at least input device (e.g., a button, dial or switch) which enables a user to control the overall speed or rate or volume of the injection by enabling the user to independently control the speed or rate or volume of the injection of each injectable fluid.
In one embodiment, the modular injection system is configured to extrude fluid at a plurality of predetermined selectable speeds. As described in more detail below, in one embodiment, the modular injection system is configured to extrude fluid at the following four different selectable speeds: very low, low, medium and high. In one embodiment, the modular injection system is configured to extrude fluid at a dynamic speed which enables extrusion of each of the four different speeds based on the amount of pressure exerted on the inject button. Lighter pressure on the inject button corresponds to a lower injection speed and a higher pressure corresponds to a higher injection speed. Approximate corresponding flow rates are shown in Table 1.
These flow rates were determined based on evaluation physician's typical extrusion rates.
In one embodiment, the input devices include at least one encoder. Using at least one encoder, the modular injection system determines the position of the plungers. For example, the modular injection system illustrated in
In one embodiment, the encoder is a rotational encoder connected to a motor. In this embodiment, the rotational encoder can be configured to sense the rotation of the motor. For example, the motor may rotate a portion of the rotational encoder.
In different embodiments, other portions of the modular injection system may be encoded. For example, in one embodiment, the modular injection system includes a separate linear encoder for each of the plungers.
Referring to
Referring to
In this embodiment, display device 200 displays first volume remaining meter 202 for the HA, and second volume remaining meter 204 for the PBS. First volume remaining meter 204 displays an amount or volume of HA remaining. At the point in time illustrated in
Display device 200 also displays first volume starting meter 206 for the HA, and second volume starting meter 208 for the PBS. First volume starting meter 206 displays an amount or volume of HA which the injection device started with before the extrusion process. In this embodiment, first volume starting meter 206 indicates that, before the extrusion process, the injection device included 2.0 mL of HA. Second volume starting meter 208 displays the amount or volume of PBS which the injection device started with before the extrusion process. In this embodiment, second volume starting meter 208 indicates that, before the extrusion process, the injection device included 2.0 mL of PBS.
Display device 200 can also displays total volume of fluid injected or extruded meter 210. Total volume of fluid injected meter 210 displays the total amount or volume of fluid which has been injected or extruded. At the points in time illustrated in
Display device 200 also displays dilution ratio meter 212. In this embodiment, dilution meter 212 displays the ratio of HA to PBS. At the point in time illustrated in
Display device 200 also displays dilution ratio increase button 214 and dilution ratio decrease button 216. In this embodiment, the user is enabled to control the specific dilution ratio by selecting dilution ratio increase button 214 and dilution ratio decrease button 216. For example, as illustrated in
Display device 200 also displays injection speed setting meter 218. In this embodiment, injection speed setting meter 218 displays the current injection speed setting of the injection device. At the point in time illustrated in
Display device 200 also displays injection speed increase button 220 and injection speed decrease button 222. In this embodiment, the user is enabled to control the specific injection rate speed by selecting injection speed increase button 220 and injection speed decrease button 222. For example, as illustrated in
In one embodiment, the modular injector system determines the ratio of the first fluid and the second fluid based on the selected injection speeds of the first fluid and the second fluid. That is, in this embodiment, the modular injection system enables a user to select a first injection rate for the first fluid and a second injection rate for the second fluid. After the injection rates have been selected or set, in response to the user selecting the inject button, the modular injection system causes each of the injectable fluids to extrude the modular injection system based on their selected injection rates.
It should be understood that, in one example, the user is enabled to cause the modular injection system to select a dilution ratio of 100% (e.g., 100% HA and 0% PBS).
In one embodiment, drive unit 140 includes a single gear motor and a transmission. For example, drive unit 1000 illustrated in
In one embodiment, drive unit 140 includes a pressure driven system which includes a pressure source (e.g., a CO2 cartridge) used to drive each plunger forward. In this embodiment, the dilution ratio is determined by regulating the flow of the fluid from each cartridge. In operation, the modular injection system enables a user to manually control the individual flow out of the cartridges using pressure/flow regulators or variable orifice valves. In one embodiment, the modular injection system electronically controls the individual flow out of the cartridges using pressure/flow regulators. Referring to
In one embodiment, drive unit 140 includes a hydraulically driven system. For example, as illustrated in
In one embodiment, drive unit 140 includes a nitinol drive system. For example, as illustrated in
In one embodiment, the drive unit includes a wire system. For example, as illustrated in
In one embodiment, the drive unit includes a pressure vessel which transmits pressure from the control device to the handheld injection device. In one embodiment, the pressure vessel transmits pressure from the control device, through tubing, to the cartridges located in the handheld injection device. As illustrated in
In one embodiment, the drive unit includes a hydraulic system where fluid lines are housed within a tether between the handheld injection device and the control device. For example, as illustrated in
In alternative embodiments, certain components of the device are housed in alternative locations. For example, as illustrated in
In this embodiment, separate control device 1704 includes a portion of the control system. That is, control device 1704 includes display device 1718; input devices 1720; at least one processor (not shown); and at least one memory device (not shown). Handheld injection device 1702 can include input device or inject button 1722.
In one embodiment, where the handheld injection device includes the drive unit, components of the handheld injection device can be configured such that the weight of the handheld injection device is effectively balanced by positioning the cartridges in the front section of the handheld injection device, and the motors in the rear section of the handheld injection device. In this embodiment, the cross section of the injection device is fairly consistent along its length.
In another embodiment, the components of the handheld injection device are configured such that configuration of the handheld injection device has a front section having a diamond shaped cross section based on the positions of the motors and the cartridges. This diamond-shaped cross section may provide improved ergonomics.
In one embodiment, the input devices include at least one sensor. For example, modular injection system 10 may include a cartridge inserted sensor. Using the cartridge inserted sensor, modular injection system 10 may detect whether at least one cartridge is inserted in the cartridge housing. The cartridge inserted sensor may prevent modular injection system 10 from attempting to perform an injection without cartridge(s) properly loaded. In one embodiment, modular injection system 10 includes a home sensor. Using the home sensor, modular injection system 10 may detect whether the injection device is in a home state.
In one embodiment, modular injection system 10 includes at least one motor driver. The motor driver can communicate with both the processor and the motor(s). The motor driver may provide the systems necessary to control the operation of the motor(s). In another embodiment, using input from sensors and encoders, the processor directs the motor(s) through the motor driver, which in turn may control the extension of the plunger and thus the injection.
In addition, modular injection system 10 may include a power system. For example, modular injection system 10 may house at least one battery, or other power source (e.g., a rechargeable battery or a fuel cell). In one embodiment, the power includes electrical power. The battery may be connected to the control system in any suitable manner. For example, the battery may be permanently connected, e.g., soldered, or may be connected through a connector. In the latter case, a door may be provided in modular injection system 10, which may allow access to the battery for removal and replacement. In one embodiment, the control device may be powered by an electrical power source, and the handheld injector unit may draw electrical power from the power source using the cable.
In addition, modular injection system 10 may include a battery charger. The battery charger may be capable of charging the at least one battery when connected to an external source of electricity. For example, modular injection system 10 may include a connector, which may allow the injector device to connect to a source of electrical power, such a standard 120 or 240 V AC power source. Of course, modular injection system 10 need not connect to such a power source directly. Rather modular injection system 10 may connect to a power adaptor or supply system, which may in turn connect to the primary power source. In addition, any suitable connector may be provided, e.g., in the body of modular injection system 10, for connection to the external power source.
In one embodiment, the modular injection system includes disposable components. In one embodiment, the disposable components include anything that may come in contact with the injectable fluids (wet components). The disposable components may also include anything which is integral to the function of the wet components. For example, the disposable components may include a needle, syringes (filled with e.g., HA and PBS), plungers, o-rings, tubing, housings, fittings and/or seals.
In one embodiment, the modular injection system includes durable components which include components intended to be reused between patients. Therefore, in one embodiment, the injection device is easily cleaned. In one embodiment, the durable components include the drive unit, battery or batteries, the user interface, the printed circuit boards and any necessary electrical connections, the disposable retention mechanism for locking disposable and durable components together, and/or housings (e.g., lids, doors, slides, etc.).
The disposable components can be loaded into the durable components in any suitable way. For example, the disposable components can be loaded into the durable components employing slide in (slot) loading, drop in (shotgun) loading, and clip in loading, or any combination of these methods.
In the preceding specification, the present disclosure has been described with reference to specific example embodiments thereof. It will, however, be evident that various modifications and changes may be made thereunto without departing from the broader spirit and scope of the present disclosure. The description and drawings are accordingly to be regarded in an illustrative rather than restrictive sense.
The terms “a,” “an,” “the” and similar referents used in the context of describing the disclosure (especially in the context of the following claims) are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein is intended merely to better illuminate the disclosure and does not pose a limitation on the scope of the disclosure otherwise claimed. No language in the specification should be construed as indicating any non-claimed element essential to the practice of the disclosure.
Groupings of alternative elements or embodiments of the disclosure disclosed herein are not to be construed as limitations. Each group member may be referred to and claimed individually or in any combination with other members of the group or other elements found herein. It is anticipated that one or more members of a group may be included in, or deleted from, a group for reasons of convenience and/or patentability. When any such inclusion or deletion occurs, the specification is deemed to contain the group as modified thus fulfilling the written description of all Markush groups used in the appended claims.
Certain embodiments of this disclosure are described herein, including the best mode known to the inventors for carrying out the disclosure. Of course, variations on these described embodiments will become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventor expects skilled artisans to employ such variations as appropriate, and the inventors intend for the disclosure to be practiced otherwise than specifically described herein. Accordingly, this disclosure includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the disclosure unless otherwise indicated herein or otherwise clearly contradicted by context.
In closing, it is to be understood that the embodiments of the disclosure disclosed herein are illustrative of the principles of the present disclosure. Other modifications that may be employed are within the scope of the disclosure. Thus, by way of example, but not of limitation, alternative configurations of the present disclosure may be utilized in accordance with the teachings herein. Accordingly, the present disclosure is not limited to that precisely as shown and described.
This application is a continuation of U.S. patent application Ser. No. 13/658,382, filed Oct. 23, 2012, which claims priority to and the benefit of U.S. Provisional Patent Application No. 61/561,752, filed Nov. 18, 2011, the entire disclosure of each of these applications being incorporated herein by this reference.
Number | Date | Country | |
---|---|---|---|
61561752 | Nov 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13658382 | Oct 2012 | US |
Child | 14253303 | US |